Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Kyra B. Berg"'
Autor:
Kyra B. Berg, MD, Peter D. Liebling, MD, Melanie J. Kubik, MD, Richard Attanoos, MD, Francoise Galateau-Salle, MD, Victor Roggli, MD, Mark Wick, MD, Andrew M. Churg, MD
Publikováno v:
Human Pathology: Case Reports, Vol 13, Iss , Pp 18-20 (2018)
Nodular mesothelial/histiocytic hyperplasia (NMHH) is a benign reactive phenomenon that can occur at any mesothelial site. We report the case of a 33 year old male who presented with chest pain and a pleural effusion, and after several months of inve
Externí odkaz:
https://doaj.org/article/494534ac92d14268814c489bca62605f
Publikováno v:
Journal of Lipid Research, Vol 50, Iss 5, Pp 988-998 (2009)
Lipid rafts are membrane microdomains involved in many cellular functions, including transduction of cellular signals and cell entry by pathogens. Lipid rafts can be enriched biochemically by extraction in a nonionic detergent at low temperature, fol
Externí odkaz:
https://doaj.org/article/cb39b385a02f44edad830b3b87e6a882
Publikováno v:
BMJ case reports. 15(3)
Tumour to tumour metastases are uncommon, and we report a case of carotid body paraganglioma metastatic to a hepatocellular adenoma. A 54-year-old man presented after a CT chest for chronic cough that incidentally identified two liver lesions in segm
Autor:
Kyra B. Berg, Françoise Galateau-Sallé, Kazuki Nabeshima, Carrie Fitzpatrick, Thomas Krausz, Jefree J. Schulte, Sanja Dacic, Nolwenn Le Stang, Kenzo Hiroshima, Stephanie M. McGregor, David B. Chapel, Aliya N. Husain, Andrew Churg
Publikováno v:
Modern Pathology. 33:245-254
Ancillary studies facilitate accurate diagnosis of morphologically challenging mesothelial proliferations. The current diagnostic algorithm proceeds from BAP1 immunohistochemistry to CDKN2A fluorescence in situ hybridization. While MTAP immunohistoch
Publikováno v:
Modern Pathology. 33:312-318
The separation of benign from malignant mesothelial proliferations is a morphologically difficult problem. Mutations/deletions of components of the Hippo pathway are frequent in malignant mesotheliomas, and one downstream effect of aberrant Hippo sig
Publikováno v:
Virchows Archiv. 476:863-870
Malignant colorectal polyps have a risk of lymph node metastases between 9 and 24%, but patients who are negative for certain histologic poor prognostic factors have the potential to be treated with polypectomy alone. Retrospective cohort of 216 mali
Publikováno v:
Cancer Cytopathology. 128:126-132
Background The separation of benign from malignant mesothelial proliferations on effusion cytology can be difficult. Loss of methylthioadenosine phosphorylase (MTAP) by immunohistochemistry is an established marker of malignancy in mesothelial prolif
Publikováno v:
Archives of Pathology & Laboratory Medicine. 142:1549-1553
Context.— The separation of reactive from malignant mesothelial proliferations is often a difficult morphologic problem. There is contradictory information in the literature on whether methylthioadenosine phosphorylase (MTAP) immunohistochemistry c
Autor:
Andrew Churg, Kyra B. Berg
Publikováno v:
American Journal of Surgical Pathology. 41:1221-1225
The separation of sarcomatoid and desmoplastic malignant mesotheliomas from sarcomatoid carcinomas of the lung metastatic to the pleura may be difficult, since both types of tumor can be morphologically similar and are frequently positive only for pa
Autor:
Richard Attanoos, Victor L. Roggli, Melanie J. Kubik, Andrew Churg, Kyra B. Berg, Peter D. Liebling, Françoise Galateau-Sallé, Mark R. Wick
Publikováno v:
Human Pathology: Case Reports, Vol 13, Iss, Pp 18-20 (2018)
Nodular mesothelial/histiocytic hyperplasia (NMHH) is a benign reactive phenomenon that can occur at any mesothelial site. We report the case of a 33 year old male who presented with chest pain and a pleural effusion, and after several months of inve